| Application no. and date | 13735811.5 (espacenet) (Federated) (European Patent Register), 20130109 | | Patent/reg. no. and date | DK/EP 2802351, 20190327 | | Publication date | 20141119 | | Priority no. and date | US 201261584629 P, 20120109 | | EP pub. no. and date |
EP 2802351 20141119 | | Effective date | | | Applicant/owner | ADC Therapeutics SA, Biopôle
Route de la Corniche 3B
1066 Epalinges, CH | | Applicant ref. no. | P81902015DK00E | | Inventor | FILION, Mario, 739 Maple Street
Longueuil, Québec J4J 4M8, CA,
TREMBLAY, Gilles, Bernard, 100 Denise-Lemaistre
La Prairie, Québec J5R 6N8, CA,
MORAITIS, Anna N., 4273 Prince-Charles avenue
Laval, Québec H7W 1Z4, CA | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/7088 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61K 47/68 (2017.01) , A61P 35/00 (2006.01) , C07K 16/18 (2006.01) , C07K 16/30 (2006.01) | | Title | Midler til behandling af triple-negativ brystkræft | | Int. application no. | CA2013000011 | | Int. publication no. | WO2013104050 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
